Pharmacogenetic study of methotrexate and 6-mercaptopurine related genes in Korean pediatric patients with acute lymphoblastic leukemia

被引：0
|
作者：
Kang, Hyoung Jin [1 ]
Seo, Young-Jin [1 ]
Lee, Chang Jin [1 ]
Kim, Hyery [1 ]
Jang, Mi Kyung [1 ]
Koh, Sang Hyeok [1 ]
Oh, Yongtaek [2 ]
Han, Byoung-Don [2 ]
Kim, Chul Woo [3 ]
Kim, Eun Kyung [1 ]
Shin, Hee Young [1 ]
Ahn, Hyo Seop [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Pediat, Seoul, South Korea
[2] YeBt Co LTD, Seoul, South Korea
[3] Dept Pathol, Seoul, South Korea
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4195.4195
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4195
引用
收藏
页码：116B / 116B
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics of two 6-mercaptopurine liquid formulations in children with acute lymphoblastic leukemia
    Tolbert, Jaszianne A.
    Bai, Shasha
    Abdel-Rahman, Susan M.
    August, Keith J.
    Weir, Scott J.
    Kearns, Gregory L.
    Neville, Kathleen A.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (08)
  • [32] Budget impact analysis of TPMT and NUDT15 pharmacogenomic testing for 6-mercaptopurine in pediatric acute lymphoblastic leukemia patients
    Fuerte, Beverly
    Burgos, Mia
    Cao, Vyvy
    Maggo, Simran
    Bhojwani, Deepa
    Rushing, Teresa
    Nguyen, Jenny Q.
    Gong, Cynthia L.
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (02): : 73 - 80
  • [33] Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia
    Schmiegelow, K
    Glomstein, A
    Kristinsson, J
    Salmi, T
    Schroder, H
    Bjork, O
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (02) : 102 - 109
  • [34] Effects on transmethylation by high-dose 6-mercaptopurine and methotrexate infusions during consolidation treatment of acute lymphoblastic leukemia
    KeuzenkampJansen, CW
    DeAbreu, RA
    Blom, HJ
    Bokkerink, JPM
    Trijbels, JMF
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (09) : 1165 - 1171
  • [35] PROGNOSTIC-SIGNIFICANCE OF METHOTREXATE AND 6-MERCAPTOPURINE DOSAGE DURING MAINTENANCE CHEMOTHERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    SCHMIEGELOW, K
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1991, 8 (04) : 301 - 312
  • [36] Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
    Tiphaine Adam de Beaumais
    Evelyne Jacqz-Aigrain
    European Journal of Clinical Pharmacology, 2012, 68 : 1233 - 1242
  • [37] Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
    de Beaumais, Tiphaine Adam
    Jacqz-Aigrain, Evelyne
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (09) : 1233 - 1242
  • [38] Extremely low dose of 6-mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations
    Zhai, Xiao-Ying
    Zhou, Yue
    Dong, Lei
    Nie, Ai-Qing
    Zhi, Li-Juan
    Jacqz-Aigrain, Evelyne
    Wang, Tian-You
    Wang, Li
    Zhao, Wei
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (01) : 74 - 77
  • [39] Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients
    Hareedy, Mohammad Salem
    El Desoky, Ehab S.
    Woillard, Jean-Baptiste
    Thabet, Romany Helmy
    Ali, Amany Mohamad
    Marquet, Pierre
    Picard, Nicolas
    PHARMACOGENOMICS, 2015, 16 (10) : 1119 - 1133
  • [40] COMPARISON OF 6-MERCAPTOPURINE WITH THE COMBINATION OF 6-MERCAPTOPURINE AND AZASERINE IN THE TREATMENT OF ACUTE LEUKEMIA IN CHILDREN - RESULTS OF A COOPERATIVE STUDY
    HEYN, RM
    BRUBAKER, CA
    BURCHENAL, JH
    CRAMBLETT, HG
    WOLFF, JA
    BLOOD, 1960, 15 (03) : 350 - 359
12345